The global marine biotechnology market was valued at USD 5.7 billion in 2021 and it is predicted to surpass around USD 10.59 billion by 2030 with a CAGR of 7.13% from 2022 to 2030.
Marine Biotechnology is the field of science of producing products from aquatic organisms with the approaches of biotechnology, cell biology, molecular biology, and bioinformatics. It deals with the development of pharmaceutical drugs, enzymes and chemical products by exploring the ocean and marine resources. It is also referred to as blue biotechnology. It includes the use of techniques like bioremediation, bioprocessing, bioharvesting, and aquaculture with the application of bioreactors.
Applications of marine biotechnology include medicine, biofuels, environment, health management, reproduction, and nutrition. For example, Reproduction: Production of fish gonadotropin hormone by crude pituitary gland preparation using recombinant DNA technology, Nutrition: Transfer of glucose and hexokinase genes in the carnivorous fish for enhancing the carbohydrate uptake metabolism, Health improvement and management: Use of polymerase chain reaction (PCR) in disease diagnosis. The National Institute of Ocean Technology of India has prepared anti-aging cosmetics from deep-sea bacteria in July 2021.
As per the research, the application of sea-based ingredients in agriculture and cosmetics is in high demand fostering the marine biotechnology market growth. The nutritional supplements made from marine-derived products are in increasing demand leading to the growth of the marine biotechnology market. Discoveries and progress in the fields of aquaculture, fishery, and drug discovery development is the key driver for the market growth. Recently, Bluu Biosciences received funding for the production of fish products from cell culture. An increase in the demand and awareness of using aquatic organisms for healthy management paves way for the industry growth.
The market is segmented by type, technology, application, end-user, and region. The type segment is bifurcated into bio active substances and bio materials. The technology segment is bifurcated into isolation and cultivation of microorganisms, and culture-independent techniques. The application segment is based on aquaculture and food products, environment and human health, and drug discovery. The end-user segment is fragmented by food industry, pharmaceutical and biotechnology industry, chemical industry, and cosmetic industry. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Europe has the major share of the marine biotechnology market due to the government's support to use sea-based products. Thus the funding and investments by the government are the driving factor for the growth of the market. North America also has better and developed healthcare and research facilities coupled with biotechnology companies producing marine-based products, thus driving industry growth.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 5.7 billion |
Revenue Forecast by 2030 | USD 10.59 billion |
Growth rate from 2022 to 2030 | CAGR of 7.13% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Type, Technology, Application, End-user, Region |
Companies Covered |
Sea Run Holdings Inc., NEB, Nofima, Lonza Group Ltd., Sams, Tequesta Bioventures, PharmaMar S.A., Abbott Laboratories, New England Biolabs Inc., Qingdao Codo International Ltd., Earthrise Nutritionals, NovaMatrix, GlycoMar Ltd., SEPPIC, Nutrex Hawai Inc., Royal DSM N.V., Biotech Marine, Aquapharm, Marinova, Prolume Ltd., Cyanotech Corporation, Aker Biomarine, CP Kelco US Inc. |
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Marine Biotechnology Market
5.1. COVID-19 Landscape: Marine Biotechnology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Marine Biotechnology Market, By Type
8.1. Marine Biotechnology Market, by Type, 2022-2030
8.1.1. Bio Active Substance
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bio Materials
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Marine Biotechnology Market, By Technology
9.1. Marine Biotechnology Market, by Technology, 2022-2030
9.1.1. Isolation and Cultivation of Microorganisms
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Culture-Independent Techniques
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Marine Biotechnology Market, By Application
10.1. Marine Biotechnology Market, by Application, 2022-2030
10.1.1. Aquaculture and Food Products
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Environment & Human Health
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Drug Discovery
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Marine Biotechnology Market, By End-user
11.1. Marine Biotechnology Market, by End-user, 2022-2030
11.1.1. Food Industry
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical and Biotechnology Industry
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Chemical Industry
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Cosmetic Industry
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Marine Biotechnology Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End-user (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)
Chapter 13. Company Profiles
13.1. Sea Run Holdings Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. NEB
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nofima
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Lonza Group Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sams
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Tequesta Bioventures
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. PharmaMar S.A.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Abbott Laboratories
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. New England Biolabs Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Qingdao Codo International Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms